Ping Ma1, Darla E Kendzor2, Insiya B Poonawalla3, David S Balis4, Michael S Businelle2. 1. Children's Health/Children's Medical Center at Dallas, Dallas, TX, United States. Electronic address: ping.ma@childrens.com. 2. University of Oklahoma Health Sciences Center, Oklahoma Tobacco Research Center, Oklahoma, OK, United States. 3. Department of Health Promotion and Behavioral Sciences, Dallas, TX, United States. 4. University of Texas Southwestern Medical Center, Department of General Internal Medicine, Dallas, TX, United States.
Abstract
INTRODUCTION: Individuals who use the nicotine patch are more likely to quit smoking than those who receive placebo or no medication. However, studies have not yet examined the association between actual daily nicotine patch wear time during the early phase of a smoking cessation attempt and later smoking abstinence. The purpose of this study was to address this gap in the literature. METHODS:Participants who enrolled in a safety-net hospital smoking cessation program were followed for 13 weeks (i.e., 1 week pre-quit through 12 weeks post-quit). Participants completed in-person assessments and daily ecological momentary assessments on study provided smartphones. Multivariate logistic regressions were used to determine if daily patch wear time during the first week post-quit predicted 7-day biochemically verified point prevalence smoking abstinence 4 and 12 weeks following the scheduled quit date. Demographic characteristics and smoking behaviors were adjusted as covariates. RESULTS:Participants (N=74) were primarily non-White (78.7%) and most (86%) had an annual household income of <$20,000. Greater average hours of daily nicotine patch wear time during the first week post-quit was associated with a greater likelihood of abstinence at the 4 and 12 week post-quit visits (aOR=2.22, 95% CI:1.17-4.23; aOR=2.24, 95% CI:1.00-5.03). Furthermore, more days of wearing the patch for ≥19h was associated with a greater likelihood of abstinence at the 4 and 12 week post-quit visits (aOR=1.81, 95% CI:1.01-3.22; aOR=2.18, 95% CI:1.03-4.63). CONCLUSIONS: Greater adherence to the nicotine patch early in a quit attempt may increase the likelihood of smoking cessation among socioeconomically disadvantaged adults. Copyright Â
RCT Entities:
INTRODUCTION: Individuals who use the nicotine patch are more likely to quit smoking than those who receive placebo or no medication. However, studies have not yet examined the association between actual daily nicotine patch wear time during the early phase of a smoking cessation attempt and later smoking abstinence. The purpose of this study was to address this gap in the literature. METHODS:Participants who enrolled in a safety-net hospital smoking cessation program were followed for 13 weeks (i.e., 1 week pre-quit through 12 weeks post-quit). Participants completed in-person assessments and daily ecological momentary assessments on study provided smartphones. Multivariate logistic regressions were used to determine if daily patch wear time during the first week post-quit predicted 7-day biochemically verified point prevalence smoking abstinence 4 and 12 weeks following the scheduled quit date. Demographic characteristics and smoking behaviors were adjusted as covariates. RESULTS:Participants (N=74) were primarily non-White (78.7%) and most (86%) had an annual household income of <$20,000. Greater average hours of daily nicotine patch wear time during the first week post-quit was associated with a greater likelihood of abstinence at the 4 and 12 week post-quit visits (aOR=2.22, 95% CI:1.17-4.23; aOR=2.24, 95% CI:1.00-5.03). Furthermore, more days of wearing the patch for ≥19h was associated with a greater likelihood of abstinence at the 4 and 12 week post-quit visits (aOR=1.81, 95% CI:1.01-3.22; aOR=2.18, 95% CI:1.03-4.63). CONCLUSIONS: Greater adherence to the nicotine patch early in a quit attempt may increase the likelihood of smoking cessation among socioeconomically disadvantaged adults. Copyright Â
Authors: Tanya R Schlam; Jessica W Cook; Timothy B Baker; Todd Hayes-Birchler; Daniel M Bolt; Stevens S Smith; Michael C Fiore; Megan E Piper Journal: Psychopharmacology (Berl) Date: 2018-04-25 Impact factor: 4.530
Authors: Emily T Hébert; Tanushri Bhushan; Chaelin K Ra; Summer Frank-Pearce; Adam C Alexander; Ashley B Cole; Darla E Kendzor; Michael S Businelle Journal: Drug Alcohol Depend Date: 2021-10-29 Impact factor: 4.492
Authors: Travis P Baggett; Yuchiao Chang; Awesta Yaqubi; Claire McGlave; Stephen T Higgins; Nancy A Rigotti Journal: Nicotine Tob Res Date: 2018-11-15 Impact factor: 4.244